전남대학교 중앙도서관

Cultural shift

뉴스

issue: Herald Sun (Melbourne). 02/18/2012, p68-68. 1.
Author: CARA JENKIN, DANIEL HOY
DB Label: Database : Regional Business News

원문보기: Full Text (원문보기)

Nomads killing our business Calls grow for crackdown on illegal campers

뉴스

issue: Cairns Post, The. 08/02/2010, p5-5. 1.
Author: Carenda Jenkin & Daniel Bateman (editorial@tcp.newsltd.com.au
DB Label: Database : Regional Business News

원문보기: Full Text (원문보기)

Reef strike ship to be checked for fuel leak

뉴스

issue: Cairns Post, The. 05/20/2010, p5-5. 1.
Author: Carenda Jenkin & Daniel Bateman
editorial@tcp.newsltd.com.au
DB Label: Database : Regional Business News

원문보기: Full Text (원문보기)

Production of optically trapped 87RbCs Feshbach molecules.

정기출판물

issue: Physical Review A: Atomic, Molecular & Optical Physics. Mar2014, Vol. 89 Issue 3-B, p1-8. 8p.
Author: Köppinger, Michael P.¹
McCarron, Daniel J.¹
Jenkin, Daniel L.¹
Molony, Peter K.¹
Hung-Wen Cho¹
Cornish, Simon L.¹
Le Sueur, C. Ruth²
Blackley, Caroline L.²
Hutson, Jeremy M.²
DB Label: Database : Academic Search Complete

원문보기: Full Text (APS)

Feshbach resonances in ultracold 85Rb.

정기출판물

issue: Physical Review A: Atomic, Molecular & Optical Physics. Mar2013, Vol. 87 Issue 3-B, p1-7. 7p.
Author: Blackley, Caroline L.¹
Sueur, C. Ruth Le¹
Hutson, Jeremy M.¹
McCarron, Daniel J.²
Köppinger, Michael P.²
Hung-Wen Cho²
Jenkin, Daniel L.²
Cornish, Simon L.²
DB Label: Database : Academic Search Complete

원문보기: Full Text (APS)

Feshbach spectroscopy of an ultracold mixture of 85Rb and 133Cs.

정기출판물

issue: Physical Review A: Atomic, Molecular & Optical Physics. Jan2013, Vol. 87 Issue 1-A, p1-5. 5p.
Author: Hung-Wen Cho¹
McCarron, Daniel J.¹
Köppinger, Michael P.¹
Jenkin, Daniel L.¹
Butler, Kirsteen L.¹
Julienne, Paul S.²
Blackley, Caroline L.³
Le Sueur, C. Ruth³
Hutson, Jeremy M.³
Cornish, Simon L.¹
DB Label: Database : Academic Search Complete

원문보기: Full Text (APS)

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

학술저널

issue: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Apr 12. Date of Electronic Publication: 2024 Apr 12.
Author: Satti I; The Jenner Institute, University of Oxford, Oxford, UK.
Marshall JL; The Jenner Institute, University of Oxford, Oxford, UK.
Harris SA; The Jenner Institute, University of Oxford, Oxford, UK.
Wittenberg R; The Jenner Institute, University of Oxford, Oxford, UK.
Tanner R; The Jenner Institute, University of Oxford, Oxford, UK.
Lopez Ramon R; The Jenner Institute, University of Oxford, Oxford, UK.
Wilkie M; The Jenner Institute, University of Oxford, Oxford, UK.
Ramos Lopez F; The Jenner Institute, University of Oxford, Oxford, UK.
Riste M; The Jenner Institute, University of Oxford, Oxford, UK.
Wright D; The Jenner Institute, University of Oxford, Oxford, UK.
Peralta Alvarez MP; The Jenner Institute, University of Oxford, Oxford, UK.
Williams N; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Morrison H; The Jenner Institute, University of Oxford, Oxford, UK.
Stylianou E; The Jenner Institute, University of Oxford, Oxford, UK.
Folegatti P; The Jenner Institute, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
Vermaak S; The Jenner Institute, University of Oxford, Oxford, UK.
Rask L; The Jenner Institute, University of Oxford, Oxford, UK.
Cabrera Puig I; The Jenner Institute, University of Oxford, Oxford, UK.
Powell Doherty R; The Jenner Institute, University of Oxford, Oxford, UK.
Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK.
Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Hinks T; Oxford Centre for Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Bettinson H; Oxford Centre for Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
McShane H; The Jenner Institute, University of Oxford, Oxford, UK. Electronic address: helen.mcshane@ndm.ox.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.

issue: BioRxiv : the preprint server for biology [bioRxiv] 2021 Dec 22. Date of Electronic Publication: 2021 Dec 22.
Author: Dejnirattisai W; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Huo J; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.
Zhou D; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Zahradník J; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Supasa P; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Liu C; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Duyvesteyn HME; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.
Ginn HM; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Mentzer AJ; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Tuekprakhon A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nutalai R; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wang B; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Dijokaite A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Khan S; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Avinoam O; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Bahar M; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.
Skelly D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Peter Medawar Building for Pathogen Research, Oxford, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Adele S; Peter Medawar Building for Pathogen Research, Oxford, UK.
Johnson SA; Peter Medawar Building for Pathogen Research, Oxford, UK.
Amini A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.; Peter Medawar Building for Pathogen Research, Oxford, UK.
Ritter T; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mason C; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dold C; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pan D; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.; Department of Respiratory Sciences, University of Leicester.
Assadi S; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.
Bellass A; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.
Omo-Dare N; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.
Koeckerling D; Medical Sciences Division, University of Oxford.
Flaxman A; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Clemens SAC; Institute of Global Health, University of Siena, Siena, Brazil; Department of Paediatrics, University of Oxford, Oxford, UK.
Naveca FG; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Amazonas, Brazil.
Nascimento V; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Amazonas, Brazil.
Nascimento F; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Amazonas, Brazil.
Fernandes da Costa C; Fundação de Vigilância em Saúde do Amazonas, Manaus, Amazonas, Brazil.
Resende PC; Laboratorio de vírus respiratórios- IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Pauvolid-Correa A; Laboratorio de vírus respiratórios- IOC/FIOCRUZ, Rio de Janeiro, Brazil.; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, United States.
Siqueira MM; Laboratorio de vírus respiratórios- IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Baillie V; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Serafin N; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ditse Z; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Da Silva K; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Madhi S; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Nunes MC; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Malik T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, UK.
Openshaw PJ; National Heart & Lung Institute, Imperial College London.
Baillie JK; Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK.
Semple MG; NIHR Health Protection Research Unit, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Townsend AR; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Huang KA; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Tan TK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Carroll MW; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, UK.
Klenerman P; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Peter Medawar Building for Pathogen Research, Oxford, UK.; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Barnes E; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Peter Medawar Building for Pathogen Research, Oxford, UK.; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Dunachie SJ; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Peter Medawar Building for Pathogen Research, Oxford, UK.; Centre For Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand, Department of Medicine, University of Oxford, Oxford, UK.
Constantinides B; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Webster H; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Crook D; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pollard AJ; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lambe T; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Paterson NG; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Williams MA; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Hall DR; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Fry EE; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.
Mongkolsapaya J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.; Siriraj Center of Research Excellence in Dengue & Emerging Pathogens, Dean Office for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Ren J; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.
Schreiber G; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Stuart DI; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.; Instruct-ERIC, Oxford House, Parkway Court, John Smith Drive, Oxford, UK.
Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
DB Label: Database : MEDLINE

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

학술저널

issue: Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.
Author: Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK.
Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK.
Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK.
Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK.
Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; The Jenner Institute, University of Oxford, Oxford, UK.
Babbage G; The Jenner Institute, University of Oxford, Oxford, UK.
Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK.
Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK.
Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK.
Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK.
Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK.
Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Hou MM; The Jenner Institute, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK.
Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK.
Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Makinson R; The Jenner Institute, University of Oxford, Oxford, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK.
Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK.
Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK.
Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA.
Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK.
Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택